The significance of increased CD80 and CD86 expression in pituitary adenomas has not been previously reported, but we hypothesize it predicts an increased reliance on CTLA-4 mediated pathway of tumor suppression. The gene discussed is CD86; the disease is pituitary gland adenoma.